ARF6 and liver cancer: Although a study reported that CD147 depletion results in a ZO-1 increase in prostate cells [42], we found that Arf6-KD reduced CD147 recycling diminished ZO-1 in liver cancer cells, and Arf6 activation restored ZO-1 turnover (Fig. 4g-i).